ArticleOncogene2019
IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo.
Lalita Guntuku et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it